Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites.
Level 5 - mechanism / opinion, no new human data
Animal model comparative study (germ-free vs. conventionally raised mice)
PubMed 19234110 · doi:10.1073/pnas.0812874106
What was done
Mass spectrometry (MS)-based metabolomic profiling was performed on plasma extracts from germ-free mice compared to conventionally raised mice. The researchers also evaluated the effect of mono-colonizing germ-free mice with the bacterium Clostridium sporogenes to assess its role in generating specific circulating metabolites.
What was found
Hundreds of molecular features were detected exclusively in one sample set, with the majority unique to conventionally raised mice. Approximately 10% of features present in both groups showed significant changes in relative signal intensity. Amino acid metabolites were particularly affected, including indoxyl sulfate and indole-3-propionic acid (IPA). IPA production was completely dependent on gut microflora and was established by colonization with Clostridium sporogenes. Phenyl-containing organic acids and host drug-like phase II metabolic responses were also substantially increased in conventional mice.
Why it matters
This study demonstrates that the gut microbiome profoundly shapes the circulating mammalian metabolome, showing that specific commensal bacteria are required to generate key bioactive molecules and can influence host drug metabolism pathways.
Limits
The study was conducted in rodent models, which may not fully reflect human physiology or gut microbial dynamics. The abstract omits sample sizes (n), absolute metabolite concentrations, effect sizes, and precise statistical values.
Cited by
- supports Around 50% of all small molecules (metabolites) found in the peripheral blood of animals and humans originate from or are modulated by the gut microbiome.